![](https://investorshub.advfn.com/uicon/822788.png?cb=1664635735)
Saturday, May 11, 2024 5:23:06 PM
That is correct—it is appropriate to ignore your posts ✅️
We are listening to regulators and we are reading peer-reviewed medical journals. Anonymous innuendo and baseless rumors should be ignored.
![](http://investorshub.advfn.com/uimage/uploads/2023/12/30/ekluugiphy.gif)
![](http://investorshub.advfn.com/uimage/uploads/2024/5/11/hnyybIMG_8424.jpeg)
https://www.prnewswire.com/news-releases/northwest-biotherapeutics-moves-from-optimization-of-flaskworks-prototype-to-fabrication-of-gmp-compliant-units-for-installation-validation-and-final-testing-prior-to-regulatory-certification-302054769.html
December 2023
![](http://investorshub.advfn.com/uimage/uploads/2023/12/28/nkeqbIMG_7077.jpeg)
https://www.prnewswire.com/news-releases/northwest-biotherapeutics-announces-that-a-marketing-authorization-application-has-been-submitted-to-the-uk-mhra-for-dcvax-l-for-glioblastoma-302021038.html
September 2023
![](http://investorshub.advfn.com/uimage/uploads/2024/5/11/phshhIMG_8427.jpeg)
https://www.prnewswire.com/news-releases/northwest-biotherapeutics-announces-that-dr-linda-liau-has-joined-the-companys-scientific-advisory-board-301924864.html
March 2023
![](http://investorshub.advfn.com/uimage/uploads/2023/12/28/svcdqIMG_7081.jpeg)
https://www.prnewswire.com/news-releases/northwest-biotherapeutics-and-advent-bioservices-announce-receipt-of-license-for-commercial-manufacturing-at-sawston-uk-facility-301776725.html
December 2022
![](http://investorshub.advfn.com/uimage/uploads/2023/12/28/kbtpqIMG_7074.jpeg)
https://www.prnewswire.com/news-releases/northwest-biotherapeutics-announces-mhra-approval-of-license-for-gmp-manufacturing-at-sawston-uk-facility-301449083.html
August 2022
![](http://investorshub.advfn.com/uimage/uploads/2023/12/28/vdczsIMG_7076.jpeg)
https://www.prnewswire.com/news-releases/northwest-biotherapeutics-announces-approval-of-pediatric-investigation-plan-pip-by-mhra-301610850.html
July 2022
![](http://investorshub.advfn.com/uimage/uploads/2023/12/28/pfpbqIMG_7078.jpeg)
https://www.prnewswire.com/news-releases/northwest-biotherapeutics-announces-filing-of-application-for-license-for-commercial-manufacturing-at-sawston-uk-facility-301581737.html
February 2022
![](http://investorshub.advfn.com/uimage/uploads/2023/12/28/lhkf[IMG_7079.jpeg)
https://www.prnewswire.com/news-releases/northwest-biotherapeutics-announces-commencement-of-cancer-vaccine-production-at-its-sawston-uk-facility-301484857.html
September 2020
![](http://investorshub.advfn.com/uimage/uploads/2024/5/11/uijbjIMG_8423.jpeg)
https://www.prnewswire.com/news-releases/northwest-biotherapeutics-acquires-flaskworks-301122058.html
![](http://investorshub.advfn.com/uimage/uploads/2022/11/14/rjw[m6B75BCC9-4218-48D3-9337-1CFDEDC7E5CF.jpeg)
https://www.nature.com/articles/s41467-024-48073-y
https://www.jci.org/articles/view/169314
https://jamanetwork.com/journals/jamaoncology/fullarticle/2798847
![Bullish](/static/images/ih2-bull.png)
Believe carefully. This is the greatest and most powerful lesson that I have learned since arriving on Earth. Examine what you believe about yourself most importantly, and then believe carefully as you interact with the world.
Recent NWBO News
- Biophma Announces Exclusive In License for Dendritic Cell Technology, Sending Shares Higher • AllPennyStocks.com • 06/17/2024 04:40:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 06/04/2024 09:11:16 PM
- Form DEF 14A - Other definitive proxy statements • Edgar (US Regulatory) • 06/03/2024 09:22:55 PM
- Form PRE 14A - Other preliminary proxy statements • Edgar (US Regulatory) • 05/22/2024 08:13:36 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 05/10/2024 09:04:57 PM
- Form NT 10-K - Notification of inability to timely file Form 10-K 405, 10-K, 10-KSB 405, 10-KSB, 10-KT, or 10-KT405 • Edgar (US Regulatory) • 03/01/2024 10:04:38 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 12/02/2023 01:31:35 AM
- Form 8-K - Current report • Edgar (US Regulatory) • 11/16/2023 10:11:54 PM
- Epazz, Inc. (OTC Pink: EPAZ) ZenaDrone Demonstration to Defense Departments of UAE and Saudi Arabia • InvestorsHub NewsWire • 11/15/2023 12:19:31 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 11/09/2023 09:30:39 PM
- Epazz, Inc. (OTC Pink: EPAZ) US Navy Collaboration ZenaDrone 1000 • InvestorsHub NewsWire • 11/09/2023 01:00:34 PM
- Epazz, Inc. (OTC Pink: EPAZ) US Navy Collaboration ZenaDrone 1000 Extreme Weather Demo • InvestorsHub NewsWire • 11/07/2023 12:29:43 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 08/09/2023 08:36:14 PM
Last Shot Hydration Drink Announced as Official Sponsor of Red River Athletic Conference • EQLB • Jun 20, 2024 2:38 PM
ATWEC Announces Major Acquisition and Lays Out Strategic Growth Plans • ATWT • Jun 20, 2024 7:09 AM
North Bay Resources Announces Composite Assays of 0.53 and 0.44 Troy Ounces per Ton Gold in Trenches B + C at Fran Gold, British Columbia • NBRI • Jun 18, 2024 9:18 AM
VAYK Assembling New Management Team for $64 Billion Domestic Market • VAYK • Jun 18, 2024 9:00 AM
Fifty 1 Labs, Inc Announces Acquisition of Drago Knives, LLC • CAFI • Jun 18, 2024 8:45 AM
Hydromer Announces Attainment of ISO 13485 Certification • HYDI • Jun 17, 2024 9:22 AM